193 results on '"Puduvalli, Vinay K."'
Search Results
2. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
3. Triethylammonium salt of a synthesized dicoumarol: Structural insight and human anti-glioblastoma activities
4. Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case–control study.
5. Multidisciplinary Management of Isocitrate Dehydrogenase–Mutated Gliomas in a Contemporary Molecularly Defined Era.
6. Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors.
7. Targeted Therapy for BRAF Mutant Brain Tumors
8. Early imaging marker of progressing glioblastoma: a window of opportunity
9. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma
10. Outcome of patients with malignant glioma and synchronous or metachronous non-central nervous system primary neoplasms
11. Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey
12. Proton Beam Craniospinal Irradiation Reduces Acute Toxicity for Adults With Medulloblastoma
13. A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin.
14. Tumor microenvironment in glioblastoma: Current and emerging concepts.
15. A multi-resolution textural approach to diagnostic neuropathology reporting
16. Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?
17. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia
18. Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma
19. Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAFV600E Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib
20. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation
21. Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic
22. Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study
23. Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures
24. Progressive multifocal leukoencephalopathy in a patient with glioblastoma
25. Papillary endothelial hyperplasia presenting as recurrent malignant glioma
26. Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma
27. Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma
28. A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme
29. Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status
30. Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors
31. Brain metastases: Biology and the role of the brain microenvironment
32. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.
33. Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis.
34. Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma
35. Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience.
36. Chemotherapy as first line treatment for oligodendroglioma
37. Phase II Study of Fenretinide (NSC 374551) in Adults With Recurrent Malignant Gliomas: A North American Brain Tumor Consortium Study
38. Safety and Pharmacokinetic Effects of TNP-470, an Angiogenesis Inhibitor, Combined With Paclitaxel in Patients With Solid Tumors: Evidence for Activity in Non–Small-Cell Lung Cancer
39. Brain Metastasis from Prostate Carcinoma
40. Phase II Trial of Temozolomide Plus the Matrix Metalloproteinase Inhibitor, Marimastat, in Recurrent and Progressive Glioblastoma Multiforme
41. 120 - Clinical Features: Neurology of Brain Tumor and Paraneoplastic Disorders
42. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas.
43. A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
44. Beyond Alkylating Agents for Gliomas: Quo Vadimus?
45. An expedited strategy for accurate and timely integrated molecular diagnosis of gliomas.
46. HSP90 inhibition depletes DNA repair proteins to sensitize acute myelogenous leukemia to nucleoside analog chemotherapeutics.
47. Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target.
48. Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
49. NAMPT Inhibitor KPT-9274 Selectively Targets Self-Renewal Capacity in Acute Myeloid Leukemia
50. Chemotherapy of High-Grade Astrocytomas in Adults.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.